Scott Myers

Scott Myers is an accomplished executive in the biopharmaceutical industry, currently serving as the Chairman of the Board at Convergent Therapeutics, Inc., and Dynavax Technologies Corporation, a company specializing in novel vaccines. With a background that includes leadership roles at Ironshore Therapeutics, Harpoon Therapeutics, and Viridian Therapeutics, Scott has extensive experience in guiding organizations through significant transitions, including acquisitions by major pharmaceutical companies like Merck and Pfizer. Scott's expertise also extends to independent directorships and advisory positions, notably at Selecta Biosciences and Qiming Venture Partners USA. Academic credentials include an MBA in Finance and International Business from The University of Chicago Booth School of Business and a Bachelor of Arts in Biology from Northwestern University.